Login / Signup
Christopher Kiff
ORCID
Publication Activity (10 Years)
Years Active: 2020-2021
Publications (10 Years): 2
Top Topics
Phase Ii Study
Data Analysis
High Grade
Advanced Non Small Cell Lung Cancer
Top Venues
PharmacoEconomics - open
PharmacoEconomics
</>
This page only lists publications with an associated author ORCID identifier.
Publications
</>
Tim S Grant
,
Darren Burns
,
Christopher Kiff
,
Dawn Lee
A Case Study Examining the Usefulness of Cure Modelling for the Prediction of Survival Based on Data Maturity.
PharmacoEconomics
38 (4) (2021)
Ben Rothwell
,
Christopher Kiff
,
Caroline Ling
,
Thor-Henrik Brodtkorb
Cost Effectiveness of Nivolumab in Patients with Advanced, Previously Treated Squamous and Non-squamous Non-small-cell Lung Cancer in England.
PharmacoEconomics - open
5 (2) (2020)